CP and COVID-19: Similarly, one of the significant takeaways from the present study includes the potential anti-viral effect of CP in severely ill COVID-19 patients across different age groups, as in the present study, we observed early resolution of SARS-CoV-2 infection based on RT-PCR on the 7th day and on the 14th day post-CP therapy and the data were found to vary significantly compared to the BST group.